Results
21,218 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale | SELL | $27K 76 sh | Jan 14, 2026 traded Jan 12, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $27K 76 sh | Jan 14, 2026 traded Jan 12, 2026 | |
Bevirt JoeBenDirector, CEO and Chief Architect, 10% Owner |
 JOBYJoby Aviation, Inc.Open-market sale |
| SELL |
| $24K 1,630 sh |
| Jan 14, 2026 traded Jan 13, 2026 |
| 36 | Garg PushkalEVP Chief R&D | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $15K 42 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 36 | McBee BranninChief Development Officer |  CRWVCoreWeave, Inc.Open-market sale · 10b5-1 plan | SELL | $387K 4,240 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $459K 1,259 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $510K 1,395 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Armenta AnthonyChief Software & Data Officer |  SERVServe Robotics Inc. /DE/Open-market sale | SELL | $56K 3,893 sh | Jan 14, 2026 traded Jan 13, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $353K 980 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $279K 778 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 35 | Frank MalcolmDirector |  FDSFACTSET RESEARCH SYSTEMS INCOpen-market sale | SELL | $308K 1,045 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $129K 1,414 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | Soule Randy10% Owner |  SAFXXCF Global, Inc.Open-market sale | SELL | $32K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 33 | Soule Randy10% Owner | SAFXXCF Global, Inc. Open-market sale | SELL | $32K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $156K 1,727 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $62K 693 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | Lo FrancisChief People Officer |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $1.41M 79.6K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 33 | Soule Randy10% Owner | SAFXXCF Global, Inc. Open-market sale | SELL | $31K 200.0K sh | Jan 14, 2026 traded Jan 9, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $215K 584 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $646K 7,255 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $193K 537 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $96K 269 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $87K 247 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $226K 624 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $93K 253 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 |  Wood Anthony J.Director, CEO and Chairman BOD, 10% Owner |  ROKUROKU, INCOpen-market sale · 10b5-1 plan | SELL | $1.58M 14.5K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $646K 7,254 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $96K 261 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $217K 607 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $168K 464 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $94K 263 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $109K 301 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale | SELL | $116K 316 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 31 | Duffy Sean P.Director, Chief Executive Officer |  OMDAOmada Health, Inc.Open-market sale | SELL | $651K 40.8K sh | Jan 14, 2026 traded Jan 13, 2026 |
| 31 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.92M 21.3K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 31 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.66M 29.8K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 31 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.59M 17.4K sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | Myles David C.CH. DISCOV. & NON-CLIN DEV OFF |  OLMAOlema Pharmaceuticals, Inc.Open-market sale | SELL | $429K 15.0K sh | Jan 14, 2026 traded Jan 14, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $30K 322 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1,654 18 sh | Jan 14, 2026 traded Jan 12, 2026 |
| 30 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $17K 182 sh | Jan 14, 2026 traded Jan 12, 2026 |